- Home
- SANM vs AXSM Comparison
SANM vs AXSM Comparison
Compare SANM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANM
- AXSM
- Stock Information
- Founded
- SANM 1980
- AXSM 2012
- Country
- SANM United States
- AXSM United States
- Employees
- SANM N/A
- AXSM N/A
- Industry
- SANM Electrical Products
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- SANM Technology
- AXSM Health Care
- Exchange
- SANM Nasdaq
- AXSM Nasdaq
- Market Cap
- SANM 3.8B
- AXSM 4.4B
- IPO Year
- SANM 1993
- AXSM 2015
- Fundamental
- Price
- SANM $69.03
- AXSM $95.84
- Analyst Decision
- SANM Sell
- AXSM Strong Buy
- Analyst Count
- SANM 2
- AXSM 14
- Target Price
- SANM $53.50
- AXSM $124.57
- AVG Volume (30 Days)
- SANM 398.4K
- AXSM 405.5K
- Earning Date
- SANM 11-04-2024
- AXSM 11-04-2024
- Dividend Yield
- SANM N/A
- AXSM N/A
- EPS Growth
- SANM N/A
- AXSM N/A
- EPS
- SANM 3.86
- AXSM N/A
- Revenue
- SANM $7,602,842,000.00
- AXSM $291,489,000.00
- Revenue This Year
- SANM N/A
- AXSM $42.50
- Revenue Next Year
- SANM $9.75
- AXSM $69.28
- P/E Ratio
- SANM $18.05
- AXSM N/A
- Revenue Growth
- SANM N/A
- AXSM 59.73
- 52 Week Low
- SANM $43.41
- AXSM $55.02
- 52 Week High
- SANM $76.84
- AXSM $98.40
- Technical
- Relative Strength Index (RSI)
- SANM 53.93
- AXSM 64.19
- Support Level
- SANM $62.76
- AXSM $89.24
- Resistance Level
- SANM $70.61
- AXSM $96.71
- Average True Range (ATR)
- SANM 1.90
- AXSM 3.66
- MACD
- SANM 0.47
- AXSM 0.02
- Stochastic Oscillator
- SANM 79.27
- AXSM 87.05
About SANM Sanmina Corporation
Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense and aerospace end markets. The company operates in two business segments: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue primarily in the United States, China, and Mexico, but has a presence around the world.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.